HOXA-AS3 and central nervous system cancer: HOXA-AS3 was highly expressed in glioma tissues and cell lines (LN229, U251, SNB19, U87, U138, and H4) and was closely associated with poor prognoses such as worse overall survival and pathological grade [26, 27].